UNDER
(CTH)
1982
ACT
RELEASED
BEEN HEALTH
HAS INFORMATION
OF
OF
DOCUMENT
FREEDOM
DEPARTMENT
THIS
THE THE
BY
ATAGI Meeting: AstraZeneca and TTS
21 July 2021, 1:00 – 2:00pm
MHRA report that majority of second dose AZ TTS cases are older cohort with significant
comorbidities
DISCUSSED:
Reassuring data on Dose 2 AZ reflecting minimal numbers of potential TTS case; continue to
monitor
Gender difference in risk and severity of TTS cases and how to describe in the weekly update
s 22
UNDER
(CTH)
1982
ACT
RELEASED
BEEN HEALTH
HAS INFORMATION
OF
OF
DOCUMENT
ATAGI co-chair summary:
DEPARTMENT
no change to AstraZeneca recom
FREEDOM mendations
THIS
add details of the severity of myocarditis in the update
THE THE
revisit work streams/work plan
BY
Meeting closed at approximately 2:10pm.
Document 20
Page 2 of 2
FOI 2917